Igor Lacík

Cell encapsulation: Promise and progress

In cell encapsulation, transplanted cells are protected from immune rejection by an artificial, semipermeable membrane, potentially allowing transplantation (allo- or xenotransplantation) without the need for immunosuppression. Yet, despite some promising results in animal studies, the field has not lived up to expectations, and clinical products based on encapsulated cell technology continue to elude the scientific community. This commentary discusses the reasons for this, summarizes recent progress in the field and outlines what is needed to bring this technology closer to clinical application.

Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates

The efficacy of implanted biomedical devices is often compromised by host recognition and subsequent foreign body responses. Here, we demonstrate the role of the geometry of implanted materials on their biocompatibility in vivo. In rodent and non-human primate animal models, implanted spheres 1.5 mm and above in diameter across a broad spectrum of materials, including hydrogels, ceramics, metals, and plastics, significantly abrogated foreign body reactions and fibrosis when compared to smaller spheres. We also show that for encapsulated rat pancreatic islet cells transplanted into streptozotocin-treated diabetic C57BL/6 mice, islets prepared in 1.5 mm alginate capsules were able to restore blood-glucose control for up to 180 days, a period more than 5-fold longer than for transplanted grafts encapsulated within conventionally sized 0.5-mm alginate capsules. Our findings suggest that the in vivo biocompatibility of biomedical devices can be significantly improved by simply tuning their spherical dimensions.

Multiscale requirements for bioencapsulation in medicine and biotechnology

Bioencapsulation involves the envelopment of tissues or biological active substances in semipermeable membranes. Bioencapsulation has been shown to be efficacious in mimicking the cells natural environment and thereby improves the efficiency of production of different metabolites and therapeutic agents. The field of application is broad. It is being applied in bioindustry and biomedicine. It is clinically applied for the treatment of a wide variety of endocrine diseases. During the past decades many procedures to fabricate capsules have been described. Unfortunately, most of these procedures lack an adequate documentation of the characterization of the biocapsules. As a result many procedures show an extreme lab-to-lab variation and many results cannot be adequately reproduced. The characterization of capsules can no longer be neglected, especially since new clinical trials with bioencapsulated therapeutic cells have been initiated and the industrial application of bioencapsulation is growing. In the present review we discuss novel Approached to produce and characterize biocapsules in view of clinical and industrial application. A dominant factor in bioencapsulation is selection and characterization of suitable polymers. We present the adequacy of using high-resolution NMR for characterizing polymers. These polymers are applied for producing semipermeable membranes. We present the pitfalls of the currently applied methods and provide recommendations for standardization to avoid lab-to-lab variations. Also, we compare and present methodologies to produce biocompatible biocapsules for specific fields of applications and we demonstrate how physico-chemical technologies such as FT-IR, XPS, and TOF-SIMS contribute to reproducibility and standardization of the bioencapsulation process. During recent years it has become more and more clear that bioencapsulation requires a multidisciplinary approach in which biomedical, physical, and chemical technologies are combined. For adequate reproducibility and for understanding variations in outcome of biocapsules it is advisable if not mandatory to include the characterization processes presented in this review in future studies.

Thermal degradation of plasticized poly(3-hydroxybutyrate) investigated by DSC

The thermal degradation of poly(3-hydroxybutyrate) (PHB) in the presence of two plasticizers (glycerol, glycerol triacetate) was investigated by differential scanning calorimetry (DSC). The thermal degradation was studied as a function of the annealing time, temperature and cooling rate after the thermal treatment. PHB thermal degradation proceeds by the random scission of the polymer chain. The presence of glycerol leads to a significant prodegradative effect on PHB presumably due to the alcoholysis reaction, while glycerol triacetate (triacetine) behaved as an almost inert additive from this point of view. Size exclusion chromatography (SEC) confirmed the results obtained by the DSC method. The data lead to the conclusion that DSC is a suitable method for estimation of PHB thermal degradation.

Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation

Cell encapsulation has already shown its high potential and holds the promise for future cell therapies to enter the clinics as a large scale treatment option for various types of diseases. The advancement in cell biology towards this goal has to be complemented with functional biomaterials suitable for cell encapsulation. This cannot be achieved without understanding the close correlation between cell performance and properties of microspheres. The ongoing challenges in the field of cell encapsulation require a critical view on techniques and approaches currently utilized to characterize microspheres. This review deals with both principal subjects of microspheres characterization in the cell encapsulation field: physico-chemical characterization and biocompatibility. The up-to-day knowledge is summarized and discussed with the focus to identify missing knowledge and uncertainties, and to propose the mandatory next steps in characterization of microspheres for cell encapsulation. The primary conclusion of this review is that further success in development of microspheres for cell therapies cannot be accomplished without careful selection of characterization techniques, which are employed in conjunction with biological tests.

Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model

Alginate microbeads and microcapsules are presently under evaluation for future cell-based therapy. Defining their inflammatory properties with regard to humans is therefore essential. A lepirudine-based human whole blood model was used as an inflammation predictor by measuring complement and leukocyte stimulation. Alginate microbeads were complement-compatible since they did not activate complement as measured by the soluble terminal complement complex (sTCC), Bb or the anaphylatoxins C3a and C5a. In addition, alginate microbeads were free of surface adherent leukocytes. In contrast, microcapsules containing poly-L-lysine (PLL) induced elevated levels of sTCC, Bb, C3a and C5a, surface active C3 convertase and leukocyte adhesion. The soluble PLL induced elevated levels of sTCC and up-regulated leukocyte CD11b expression. PMCG microcapsules containing poly(methylene-co-guanidine) complexed with sodium alginate and cellulose sulfate triggered a fast sTCC response and C3 deposition. The PMCG microcapsules were still less activating than PLL-containing microcapsules as a function of time. The amounts of anaphylatoxins C3a and C5a were diminished by the PMCG microcapsules, whereas leukocyte adherence demonstrated surface activating properties. We propose the whole blood model as an important tool for measuring bioincompatibility of microcapsules and microbeads for future applications as well as determining the mechanisms leading to inflammatory reactions.

Encapsulation of Human Islets in Novel Inhomogeneous Alginate-Ca2+/Ba2+ Microbeads : In Vitro and In Vivo Function

Microencapsulation may allow for immunosuppression-free islet transplantation. Herein we investigated whether human islets can be shipped safely to a remote encapsulation core facility and maintain in vitro and in vivo functionality. In non-encapsulated islets before and encapsulated islets after shipment, viability was 88.3±2.5 and 87.5±2.7% (n=6, p=0.30). Stimulation index after static glucose incubation was 5.4±0.5 and 6.3±0.4 (n=6, p=0.18), respectively. After intraperitoneal transplantation, long-term normoglycemia was consistently achieved with 3,000, 5,000, and 10,000 IEQ encapsulated human islets. When transplanting 1,000 IEQ, mice returned to hyperglycemia after 30-55 (n=4/7) and 160 days (n=3/7). Transplanted mice showed human oral glucose tolerance with lower glucose levels than non-diabetic control mice. Capsules retrieved after transplantation were intact, with only minimal overgrowth. This study shows that human islets maintained the viability and in vitro function after encapsulation and the inhomogeneous alginate-Ca2+/Ba2+ microbeads allow for long-term in vivo human islet graft function, despite long-distance shipment.

Critically evaluated rate coefficients for free-radical polymerization. Part 6: Propagation rate coefficient of methacrylic acid in aqueous solution

Critically evaluated propagation rate coefficients, kp, for free-radical polymerization of methacrylic acid, MAA, in aqueous solution are presented. The underlying kp values are from two independent sources, which both used the IUPAC-recommended technique of pulsed-laser-initiated polymerization (PLP) in conjunction with molar mass distribution (MMD) analysis of the resulting polymer by size-exclusion chromatography (SEC). Different methods of measuring the MMD of the poly(MAA) samples have, however, been used: (i) direct analysis via aqueous-phase SEC and (ii) standard SEC with tetrahydrofuran as the eluent carried out on poly(methyl methacrylate) samples obtained by methylation of the poly(MAA) samples from PLP. Benchmark kp values for aqueous solutions containing 15 mass % MAA are presented for temperatures between 18 and 89 °C. The Arrhenius pre-exponential and activation energy of kp at 15 mass % MAA are 1.54 × 106 L mol-1 s-1 and 15.0 kJ mol-1, respectively. Also reported are critically evaluated kp values for 25 °C over the entire MAA concentration range from dilute aqueous solution to bulk polymerization.

Critically evaluated rate coefficients in radical polymerization – 7. Secondary-radical propagation rate coefficients for methyl acrylate in the bulk

Propagation rate coefficient (kp) data for radical polymerization of methyl acrylate (MA) in the bulk are critically evaluated and a benchmark dataset is put forward by a task-group of the IUPAC Subcommittee on Modeling of Polymerization Kinetics and Processes. This dataset comprises previously published results from three laboratories as well as new data from a fourth laboratory. Not only do all these values of kp fulfill the recommended consistency checks for reliability, they are also all in excellent agreement with each other. Data have been obtained employing the technique of pulsed-laser polymerization (PLP) coupled with molar-mass determination by size-exclusion chromatography (SEC), where PLP has been carried out at pulse-repetition rates of up to 500 Hz, enabling reliable kp to be obtained through to 60 °C. The best-fit – and therefore recommended – Arrhenius parameters are activation energy EA = 17.3 kJ mol−1 and pre-exponential (frequency) factor A = 1.41 × 107 L mol−1 s−1. These hold for secondary-radical propagation of MA, and may be used to calculate effective propagation rate coefficients for MA in situations where there is a significant population of mid-chain radicals resulting from backbiting, as will be the case at technically relevant temperatures. The benchmark dataset reveals that kp values for MA obtained using PLP in conjunction with MALDI-ToF mass spectrometry are accurate. They also confirm, through comparison with previously obtained benchmark kp values for n-butyl acrylate, methyl methacrylate and n-butyl methacrylate, that there seems to be identical family-type behavior in n-alkyl acrylates as in n-alkyl methacrylates. Specifically, kp for the n-butyl member of each family is about 20% higher than for the corresponding methyl member, an effect that appears to be entropic in origin. Furthermore, each family is characterized by an approximately constant EA, where the value is 5 kJ mol−1 lower for acrylates.

Pancreatic cell immobilization in alginate beads produced by emulsion and internal gelation

Alginate has been used to protect transplanted pancreatic islets from immune rejection and as a matrix to increase the insulin content of islet progenitor cells. The throughput of alginate bead generation by the standard extrusion and external gelation method is limited by the rate of droplet formation from nozzles. Alginate bead generation by emulsion and internal gelation is a scaleable alternative that has been used with biological molecules and microbial cells, but not mammalian cells. We describe the novel adaptation of this process to mammalian cell immobilization. After optimization, the emulsion process yielded 90 ± 2% mouse insulinoma 6 (MIN6) cell survival, similar to the extrusion process. The MIN6 cells expanded at the same rate in both bead types to form pseudo‐islets with increased glucose stimulation index compared to cells in suspension. The emulsion process was suitable for primary pancreatic exocrine cell immobilization, leading to 67 ± 32 fold increased insulin expression after 10 days of immobilized culture. Due to the scaleability and broad availability of stirred mixers, the emulsion process represents an attractive option for laboratories that are not equipped with extrusion‐based cell encapsulators, as well as for the production of immobilized or encapsulated cellular therapeutics on a clinical scale. Biotechnol. Bioeng. 2011;108: 424–434.